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Abstract We have previously purified and characterized a 
ubiquitous non-histone protein (NHP1) which has a high affinity 
(Kd 10 -n  M) for different avian vitellogenin gene sequences 
containing CpGs (Hughes et al. (1989) Biochemistry 28, 9137- 
9142; Hughes and Jost (1989) Nucleic Acids Res. 17, 8511- 
8520). Here we show by microsequencing that the peptides 
derived from the purified p75 and p85 subunits of NHP1 from 
HeLa cells have between 64 and 100% identity with the human 
Ku autoantigen. During the differentiation of human HL-60 
promyelocytes there is an increase in the amount of p85 subunit 
protein whereas the level of the p75 subunit is unchanged. In 
differentiating mouse G8 myoblasts there is, however, an 
upregulation of both the p75 and p85 subunits and of the p85 
mRNA. An inhibition of mouse myoblast differentiation by either 
cAMP, 3-aminobenzamide or sodium butyrate abolishes the 
upregulation of the p85 subunit. In G8 myoblasts chemical, or 
physical stress by UV fight or X-rays does not upregulate the 
level of the p85 subunit. The possible involvement of NHP1 in the 
active demethylation of bifilarly methylated DNA will be 
discussed. 
Key words: Ku; Peptide microsequencing; 
DNA demethylation; Differentiation 
I. Introduction 
Non-histone protein 1 (NHP1) was first detected as a pro- 
tein with a very high affinity to the estrogen response lement 
(ERE) of the avian vitellogenin gene [1-3]. The strongest con- 
tact points of NHP1 with the ERE were with 5' AGCG 3' in 
the center of the palindrome differing from those of the estra- 
diol receptor (ER) [2]. Of the two polypeptides p75 and p85 
forming NHP1 only the p85 subunit can be crosslinked to the 
bromodeoxyuridine-substituted synthetic ERE by UV irradia- 
tion [2]. NHP1 can be separated from the estradiol receptor 
chromatographically and it neither binds estradiol nor cross 
reacts with antibodies directed against estradiol receptor. De- 
letion of the CpG in the center of the dyad symmetry se- 
quence of the ERE decreased the binding of NHP1 by 90% 
and a conversion of any GC pair to an AT pair diminished 
the affinity of the binding site for NHP1 [1]. In the purified 
form, but not in the pure form, NHP1 was shown to produce 
nicks around the central CpG of the ERE [2] indicating that 
NHP1 might play a role in the active demethylation of 
mCpGs. Furthermore, at the onset of active demethylation 
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of the avian vitellogenin gene in the liver there was a transient 
increase in NHP1 binding activity [4]. It has also been sug- 
gested that NHP1 could tag the DNA for the subsequent 
binding of the estradiol receptor [1-3]. A possible involvement 
of NHP1 in a general mechanism of active demethylation 
could account for its apparent ubiquity. Here we show that 
NHP1 is a member of the Ku autoantigen protein family and 
that it is upregulated in differentiating mouse myoblasts, a 
system known to undergo genome-wide demethylation. We 
hypothesize that NHP1 may be part of an enzyme complex 
involved in the active demethylation of DNA. 
2. Materials and methods 
2.1. Protein purification and sequencing of peptides 
NHPI was purified from HeLa cells as described previously [2]. The 
purified NHPI subunits were subjected to preparative SDS-polyacryl- 
amide gel electrophoresis and transferred to PCGM glass paper in 50 
mM sodium borate containing 0.02°,/o Nonidet P-40 at 60 V and 0.2 A. 
The single polypeptide bands were cut out and their sequence deter- 
mined directly from the PCGM paper by Edman degradation (pep- 
tides 1 and 2). Alternatively the purified polypeptides were cleaved 
with cyanogen bromide, digested with trypsin and the derived peptides 
were separated by HPLC and sequenced by Edman degradation (pep- 
tides 3 7). 
2.2. Cell culture and treatment of cells 
Mouse G8 myoblast cells were grown on collagen-coated plates in 
Dulbecco's modified Eagle's medium (DMEM) containing 4.5 g/1 glu- 
cose, 10% heat-inactivated fetal calf serum and 10% horse serum at 
37°C and 5% CO2. Differentiation was induced by changing to 
DMEM supplemented with 4.5 g/1 glucose and 2% heat-inactivated 
fetal calf serum at a cell confluence of 80-90%. Where indicated, 1mM 
8-bromo-cAMP or 5 mM sodium butyrate dissolved in DMEM were 
added to the culture medium. 3-Aminobenzamide was dissolved in 
dimethylsulfoxide (DMSO) and added to the culture at a concentra- 
tion of 5 mM. The final concentration of DMSO was 0.5%. In UV 
irradiation experiments he cells were exposed to UV-C radiation (254 
nm) using Philips TUV 15 W lamps. X-ray irradiation experiments 
were carried out in a Mtiller RT 250 X-ray generator at 15 mA and 
250 kV. Human HL-60 promyelocytes were grown in suspension cul- 
ture in RPMI 1640 medium containing 10% heat-inactivated fetal calf 
serum. Differentiation was induced at a cell density of 2.5 x 105 cells/ 
ml by the addition of DMSO to a final concentration of 1.25'7o. 
2.3. Antiserum preparation and antibody purification 
Antisera were obtained by injecting rabbits with purified histone HI 
using standard techniques [5]. For NHPI antisera, the C-terminal 
peptides KKQELLEALTKHFQD (p75) or AVFEEGGDVDDLLD- 
MI (p85) coupled to keyhole limpet hemocyanin were used for im- 
munization [5]. Peptide antisera were purified over a peptide affinity 
column containing the p75 or p85 antigenic peptide coupled to cyano- 
gen bromide-activated Sepharose 4B (Pharmacia). Purified antibodies 
were dialyzed against PBS+50% glycerol and concentrated in a Cen- 
triprep-10 (Amicon). 
2.4. Western blot analysis and creatine kinase activity determination 
Nuclear and cytoplasmic extracts were prepared according to 
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Schreiber et al. [6], protein concentration being measured by the Brad- 
ford assay [7] using the Bio-Rad protein determination system. Equal 
amounts of nuclear protein (5 or 30 gg) were separated on 7.5 or 12% 
SDS-polyacrylamide g ls [8]. Proteins were transferred to nitrocellu- 
lose BA-S 85 filters (Schleicher and Schuell) in a semi-dry transfer 
apparatus (Teknomara) at 0.8 mA/cm 2 for 1.5 h. The membranes 
were treated for 16 h at 4°C in blocking solution (10°/,, non-fat dry 
milk in PBS, 0.1% Tween 10). NHP1 p75 and p85 antibodies or 
histone HI antiserum were used at a dilution of 1:500 in blocking 
solution and incubated for 16 h at 4°C. Secondary antibody (anti- 
rabbit lgG, Bio-Rad) was diluted 1:5000 and incubated for 1 h at 
room temperature in the blocking solution. For the detection of the 
antibody reaction products, membranes were incubated for 1 rain in a 
luminol-based detection solution (ECL, Amersham). Membranes were 
exposed immediately for various times to Kodak BioMax or X- 
OMAT films. Creatine kinase activity from 4 gg of cytoplasmic pro- 
tein from G8 cells was determined colorimetrically b  the Voges-Pros- 
kauer reaction [9]. 
2.5. Northern blot analysis 
Total RNA from G8 myoblasts was isolated according to the pro- 
cedure of Chomczynski and Sacchi [10] except hat the RNA was 
dissolved in diethylpyrocarbonate-treated (DEPC) water before stor- 
age at -80°C. Poly(A) mRNA was purified from 100 gg total RNA 
on Dynabeads Oligo (dT)2s (Dynal) according to the manufacturer's 
instructions. 1 gg of poly(A) RNA was separated on a denaturing 
agarose gel containing 2.2 M formaldehyde asdescribed by Sambrook 
et al. [11]. Upon capillary transfer to Hybond Nylon membrane 
(Amersham), the RNA was immobilized by UV-crosslinking [12]. 
18S and 28S rRNA were visualized by staining the membrane with 
0.3% methylene blue. Prehybridization was performed in 6×SSC, 
5×Denhardt's, 0.5% SDS, 0.05% sodium pyrophosphate and 0.1 
mg denatured herring sperm DNA at 42°C for up to 2 h. Hybridiza- 
tion was carried out at 42°C for 16 h in 6×SSC, l×Denhardt's, 
0.05% sodium pyrophosphate, 0.1 mg/ml denatured herring sperm 
DNA containing a kinase-labeled synthetic oligonucleotide comple- 
mentary to positions 246-300 of the p85 cDNA [13] at 4× 106 cpm/ 
ml. Washing of the membrane was performed at room temperature in 
4×, 2×, 0.5 and finally 0.1×SSC for 10 rain each. Blots were ex- 
posed to X-OMAT films for 18 h. 
3. Results 
3.1, NHP1 is" a member o f  the Ku protein family 
Since NHP1 binds the estrogen response lement with a 
very high affinity (Kd of 10 -11 M) we were interested in 
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Fig. 1. Western blot showing the upregulation of the NHP1 subunits p75 and p85. Western blots of nuclear extracts (5 gg of protein per lane) 
were carried out as outlined in section 2. The left-hand panels show the Western blots of p85, p75 and histone HI from differentiating mouse 
G8 myoblasts whereas those on the right-hand side show Western blots of p85, p75 and histone HI from human HL-60 promyelocytes. Track 
0 shows material from the dividing non-differentiating cells and tracks 1 5 are the days following the onset of differentiation. 
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further characterizing this protein. Table l shows the amino 
acid sequences obtained from peptides derived from the p75 
and p85 subunits. Searches in the GenBank and EMBL se- 
quence databases revealed a high degree of homology between 
the NHP1 p75 and p85 peptides and the p72 and p86 subunits 
of the human Ku protein. The identity was 70 and 85.7% for 
the peptides derived from the p75 subunit and between 64.3 
and 100% for the p85 subunit. 
A 
3.2. Regulation of NHP1 during the differentiation of mouse 
G8 myoblasts and human HL-60 promyelocytes 
Since it has been reported that NHP1 DNA binding activity 
was upregulated by estradiol during the active demethylation 
of the avian vitellogenin gene [4] we decided to follow the 
amount of NHP1 during the genome-wide demethylation f
mouse myoblasts. As shown in the left-hand panel of Fig. 1 
(G8) the level of the p75 and p85 subunits increased progres- 
sively during the differentiation of myoblasts while histone 
HI, which was used as an internal standard, remained con- 
stant. Fig. 3A shows the time course of mouse myoblast dif- 
ferentiation was followed by using muscle creatine kinase ac- 
tivity as a marker. 
Table 1 
Comparison of the amino acid sequences of peptides derived from 
NHP1 and the Ku autoantigen 
p85 
Peptide 1 VRSGNKAAVV LXY  
I I I I  I I I J I I f  
Ku(p86) 2 VR S GNKAAVVLCM 14 
% identity 84.6 
Peptide2 C SGNXAAVVLCXSY 
I I I  I I  I I I  I 
Ku(p86) 3 R SGNKAAVVLC MDV 16 
% identity 64.3 
Peptide3 IQPGSQQAD FL  DAL I  V 
I I I  I I I  I I  I I I I  I I I I  
Ku(p86) 98 I Q PG S QQ AD F L DA L I V 113 
% identity 100.0 
Peptide 4 KXAPTEAQLNAVDAL IDXR 
I I I J  J l  I I I  I I I  I I I I  
Ku(p86) 443 KYAPTEAQ LNAVDAL I  DSM461 
% identity 84.2 
Peptide5 LED L FPG 
Ir  I I I  I 
Ku(p86) 473 L E D L F P T 479 
% identity 85.7 
pTs 
Peptide6 K I  LVLQELDNPGAK 
I [ I I IP J I I I  I I 
Ku(p72) 101 N IYVLQELDNPGAK 114 
% identity 85.7 
Peptide7 S LELDQF KXS 
I I I I  I I I 
Ku(p72) 117 I L E LD Q F K GQ 126 
% identity 70.0 
Peptides 1-5 are from the p85 subunit whereas peptides 6 and 7 are 
from the p75 subunit of NHP1. The amino acid sequences of the 
subunits are aligned with the corresponding sequence of the Ku pro- 
tein. Identical residues are indicated by vertical bars. The numbers on 
the lower sequence indicate the amino acid position in the human Ku 
protein [13,4346]. 
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Fig. 2. Northern blot analysis of poly(A) mRNA from untreated 
(day 0) and differentiating mouse G8 myoblasts (days 1 to 5)~ Ex- 
periments were carried out as outlined in section 2. (A) Hybridiza- 
tion product of the labeled p85 oligonucleotide probe to poly- 
(A)mRNA. (B) Methylene blue staining of the above membrane 
prior to hybridization. 
Addition of 1.25% DMSO to human HL-60 promyelocytes 
triggers their differentiation along the granulocyte pathway 
[14]. The progress of differentiation was monitored by mor- 
phological and biochemical changes in the cell (not shown). 
The immunoblots in the right-hand panels of Fig. 1 (HL-60) 
demonstrate hat the two subunits p75 and p85 are regulated 
quite differently. An increase in the level of p85 was observed 
after the first day of differentiation whereas the level of the 
p75 subunit showed no change during differentiation. 
The level of expression from the p85 gene during the course 
of G8 myoblast differentiation, was assayed by the hybridiza- 
tion of a radiolabeled antisense oligonucleotide to poly(A) 
mRNA. Fig. 2 shows that the non-differentiating cells had a 
very low level of p85 mRNA while differentiation resulted in a 
substantial increase in p85 mRNA. 
3.3. Effect of inhibition of G8 myoblast differentiation on the 
expression of NHP1 
It is known that myogenesis can be inhibited by the addi- 
tion of either cyclic AMP [15], 3-aminobenzamide [16] or so- 
dium butyrate [17,18] to the differentiation medium. Recently, 
we have also shown that the inhibition of differentiation by 3- 
aminobenzamide resulted in the suppression of the genome- 
wide demethylation [19]. Fig. 3A shows that the presence of 
1 mM 8-bromo-cAMP in the tissue culture medium inhibited 
the increase in creatine kinase activity and the upregulation of
p85 (Fig. 3B). 3-Aminobenzamide is another inhibitor of 
mouse myoblast differentiation which inactivates ADP-ribo- 
syltransferase, anenzyme ssential in DNA repair [20]. 5 mM 
3-aminobenzamide also inhibited the upregulation of muscle 
creatine kinase (Fig. 3A) and of NHP1 p85 subunit (Fig. 3C). 
Finally, 5 mM sodium butyrate, another inhibitor of myogen- 
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Fig. 3. Effect of inhibitors of myoblast differentiation  the upregulation of NHP1. (A) Creatine kinase (CK) activity in G8 mouse myoblasts. 
(Open bars) Denote the activity of creatine kinase in differentiating myoblasts in the absence of inhibitors, whereas (descending hatched bars) 
contained 1mM cAMP, (ascending hatched bars) 5 mM 3-aminobenzamide or (cross-hatched bars) 5 mM sodium butyrate. The data are the 
means of three independent experiments_+ S.D. (B-D) Western blots of mouse G8 myoblasts grown in the presence of cAMP (B), 3-aminoben- 
zamide (C) and sodium butyrate (D). Each lane contained 30 gg of nuclear extract. 
esis [17,18], also inhibited the increase in immunoreactive p85 
(Fig, 3D). When the results of Figs. 1, 3 and 4 are compared it
is noticeable that there was a much stronger signal for the 
zero time points of Figs. 3 and 4 than for Fig. 1. This was 
due to the overexposure of the Western blot in Figs. 3 and 4. 
In addition, in Figs. 3 and 4 we had 30 gg of nuclear extract 
per lane instead of the 5 gg used in Fig. 1. This was necessary 
for the visualization of the extremely low concentrations of 
p85 in this series of experiments. 
3.4. Physical and chemical stress do not lead to upregulation ~[ 
NHP1 
It has been proposed that Ku is involved in DNA recom- 
bination and repair [21 32] and it is known that some of the 
proteins involved in DNA repair are upregulated by DNA 
damage [33-39]. Therefore, with NHP1 being a member of 
the Ku protein family, it was of interest to see whether chem- 
ical stress or DNA damage could upregulate NHP1. Dividing 
G8 myoblasts were treated with 1% DMSO or various doses 
of UV light and X-rays. DMSO treatment of G8 myoblasts 
did not lead to any increase in NHP1 levels (Fig. 4A). 
Furthermore, 1% of DMSO had no effect on the differentia- 
tion or the activity of creatine kinase either (data not shown). 
Similarly, various doses of X-rays or UV light had no detect- 
able effect on the level of the p85 protein (Fig. 4B and C). 
Testing of even earlier time points did not reveal any transient 
upregulation of p85 (data not shown). 
4. Discussion 
We have shown previously that NHP1 binds in a sequence- 
independent manner and with a high binding affinity to DNA 
containing CpG base pairs [1,2]. The binding activity of 
NHP1 increases more than 2-fold in the liver of estradiol 
treated immature roosters where it coincides with the active 
demethylation f CpGs situated within the promoter region of 
the vitellogenin gene [4]. Similarly, we show here that there is 
an increase in the NHP1 p75 and p85 subunits during the 
differentiation of mouse G8 myoblasts. In previous experi- 
ments we have shown that during mouse G8 myoblast differ- 
entiation there is a genome-wide demethylation [19]. More- 
over, in G8 myoblasts the kinetics of the increase in NHP1 
ran in parallel with an increase in 5-methyldeoxycytidine ex- 
cision repair activity [19], where one of the key enzymes re- 
sponsible for the active demethylation is 5-methylcytosine- 
DNA glycosylase [40]. In sharp contrast, in teratocarcinoma 
cells where passive DNA demethylation ( on-enzymatic de- 
methylation) occurs during differentiation, there was no in- 
crease in either NHP1 or 5-methylcytosine-DNA glycosylase 
activity (data not shown). To our surprise, the size of the 
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Fig. 4. Chemical or physical stress to G8 mouse myoblasts did not 
upregulate the p85 subunit of NHP1. Western blots were carried 
out as above with 30 ~tg of nuclear extracts. (A) Dividing G8 myo- 
blasts (day 0) and cells treated with 1% DMSO for between 1 and 5 
days. (B) Effect of UV light (254 nm) on the level of p85. G8 myo- 
blasts were grown in medium without irradiation (lane 1) or the 
cells were irradiated with I0 J/m 2 (lanes 2,5), 50 J/m 2 (lanes 3,6) or 
200 J/m s (lanes 4,7). (C) Effect of X-ray irradiation on the level of 
the p85 protein. G8 myoblasts were grown in medium without irra- 
diation (lanes 1,2,6) or after irradiation with 1 Gray (Gy) (lanes 
3,7), 10 Gy (lanes 4,8) or 20 Gy (lanes 5,9). The cells were har- 
vested 4 h (lanes 2-5) or 1 day after irradiation (lanes 6-9). 
NHP1 subunits and the amino acid sequence of the peptides 
derived from both subunits have a high identity with the het- 
erodimeric Ku autoimmune antigen. As already shown by 
other groups the Ku protein is involved in DNA repair and 
DNA recombination [21-32]. For these reasons we thought 
that NHP1 may be related to the active demethylation of 
DNA. In the present case, how could NHP1 or Ku participate 
in the process of active DNA demethylation? We have shown 
that the active DNA demethylation of specific sites in the 
vitellogenin promoter occurred in non-dividing mature hepa- 
tocytes on both DNA strands simultaneously [3,41]. Even in 
cases where one strand is demethylated before its complemen- 
tary DNA the reaction proceeds to completion on both 
strands simultaneously [42]. Should DNA demethylation oc- 
cur through the mechanism of base excision repair, it is clear 
that the simultaneous reaction on both strands would lead to 
DNA double strand breaks and the gene would be cut into 
two or more pieces. In order to avoid double strand breaks on 
a symmetrical CpG it is conceivable that NHP1 could act like 
the Ku protein by binding to the extremities of broken 
strands, holding them together during the process of base 
excision repair. I f  this hypothesis is correct then the inhibition 
or the knocking-out of  the NHP1 genes in G8 myoblasts 
should generate numerous double strand breaks in the DNA 
during differentiation. 
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